FibroBiologics, Inc. Common Stock (FBLG)

FibroBiologics, Inc. Common Stock (FBLG) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $8M; returns 1 day -6.9%, 1 week -2.2%, 1 year -88.4%.

FibroBiologics Inc. (FBLG) is a clinical-stage biotechnology company primarily focused on developing novel fibroblast-based therapies and fibroblast-derived materials to treat and potentially cure chronic diseases with significant unmet medical needs.

Groups FBLG belongs to

• Biotechnology
• Recent Reverse Splits
• Clinical Stage Biotech
• Clinical Stage
• Regenerative Medicine
• Healthcare
• Unmet Medical Needs
• Life Sciences
• Autoimmune Diseases

FBLG financial model: income statement, cash flow and balance sheet